◇ Compound Reference
Triple Agonist · 20mg
Larger 20mg vial of Retatrutide - cost-efficient per mg for sustained weekly maintenance dosing.
Triple Agonist · 20mg per vial · dispensed after a physician review.
Every 100 units are drawn from one lot and tested once. The certificate below is the one that applies to this batch - when it closes, the next opens with a new lot and a new certificate.
Retatrutide is verified and lot-tested, dispensed following a Biological Audit. The Audit is complimentary for the Batch 001 cohort.
Are you 18 years of age or older?